MRT-2359

· Monte Rosa Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRT-2359, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Oral MRT-2359 in Selected Cancer Patients [Phase 1, Phase 2]